explore -WSS

explore

author：entertainment 2025-10-01 00:45:51 - browse：4

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： How to convince healthy people to buy insurance

leisure time

hotspot

WSS

After Sarepta trial failure, Duchenne families brace for more debate

In early work, researchers turn to CRISPR to treat Alzheimer's

Life sciences investors close nearly $6 billion in new funds

How dance can help nurses traumatized by Covid

Gene therapy’s promise and the high cost of hope

How to convince healthy people to buy insurance

entertainment

explore

explore

Peter Hotez and the public health issue of online harassment

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Hepatitis C has a cure — but many Americans still lack access to it

Medicare must police algorithms in Medicare Advantage, Dems say

Supreme Court strikes down use of affirmative action

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Medical leaders decry Supreme Court decision on affirmative action

How to convince healthy people to buy insurance

Supreme Court strikes down use of affirmative action

Sanofi seeks simpler, safer CRISPR sickle cell cure

hotspot

Explaining an after

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

In early work, researchers turn to CRISPR to treat Alzheimer's

Prime Medicine says its gene editing passes test in monkeys

FDA approves RSV monoclonal antibody for infants, toddlers

Startup Neumora takes a novel depression drug to Phase 3

leisure time

hotspot

explore

focus